Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Arteriosclerosis, Thrombosis, and Vascular Biology|March 5, 2005
Atherogenesis in mice does not require CD40 ligand from bone marrow-derived cellsUdo Bavendiek, Andreas Zirlik, Samantha LaClair, et al.
Cardiovascular and Interventional Radiology|March 29, 2023
Genicular Artery Embolization as a Treatment for Osteoarthritis Related Knee Pain: A Systematic Review and Meta-analysisYan Epelboym, Jacob C Mandell, Jamie E Collins, et al.
The American Journal of Pathology|May 18, 2010
Cystatin C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic miceStephanie Schulte, Jiusong Sun, Peter Libby, et al.
Circulation|October 21, 2009
CC chemokine receptor-1 activates intimal smooth muscle-like cells in graft arterial diseaseKoichi Shimizu, Manabu Minami, Rica Shubiki, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 3, 2007
TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cellsAndreas Zirlik, Udo Bavendiek, Peter Libby, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 14, 2007
Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart StudyAndreas Zirlik, Shuaib M Abdullah, Norbert Gerdes, et al.
Circulation|March 21, 2007
CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1Andreas Zirlik, Christoph Maier, Norbert Gerdes, et al.
Osteoarthritis and Cartilage|November 8, 2023
Causal relationships between pain, medical treatments, and knee osteoarthritis: A graphical causal model to guide analysesHaadiya Cheema, Robert Brophy, Jamie Collins, et al.
Circulation|April 28, 2010
Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wallAnna Missiou, Natascha Köstlin, Nerea Varo, et al.
Annals of the Rheumatic Diseases|April 5, 2023
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritisAnne R Bass, Noha Abdel-Wahab, Pankti D Reid, et al.
Pageof 2